Cargando…
Clinical impact of LH rises prior to and during ganirelix treatment started on day 5 or on day 6 of ovarian stimulation
BACKGROUND: We sought to evaluate the incidence and clinical impact of luteinizing hormone (LH) rises prior to and during gonadotropin-releasing hormone (GnRH) antagonist treatment started on day 5 or 6 of ovarian stimulation with recombinant follicle-stimulating hormone (rFSH). METHODS: Pooled data...
Autores principales: | Frattarelli, John L, Hillensjö, Torbjörn, Broekmans, Frank J, Witjes, Han, Elbers, Jolanda, Gordon, Keith, Mannaerts, Bernadette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847921/ https://www.ncbi.nlm.nih.gov/pubmed/24028076 http://dx.doi.org/10.1186/1477-7827-11-90 |
Ejemplares similares
-
Ganirelix and the prevention of premature luteinizing hormone surges
por: Mannaerts, Bernadette
Publicado: (2023) -
Prognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocol
por: Broekmans, Frank J., et al.
Publicado: (2014) -
Correlation of the Day 3 FSH/LH Ratio and LH Concentration in Predicting IVF Outcome
por: Prasad, Sudha, et al.
Publicado: (2013) -
Letter to Editor on “Correlation of the Day 3 FSH/LH Ratio and LH Concentration in Predicting IVF Outcome”
por: Morgante, Giuseppe
Publicado: (2014) -
LH level on the antagonist administration day as a predictor of the reproductive outcomes in women with normal ovarian function
por: Pang, Conghui, et al.
Publicado: (2023)